US 11,814,669 B2
Blood sample assay method
Arne Ludvig Faaren, Oslo (NO); Frank Frantzen, Oslo (NO); Arne Kristian Nordhei, Oslo (NO); Erling Sundrehagen, Oslo (NO); and Lars Ørning, Oslo (NO)
Assigned to ABBOTT RAPID DIAGNOSTICS INTERNATIONAL UNLIMITED COMPANY, Dublin (IE)
Filed by ABBOTT RAPID DIAGNOSTICS INTERNATIONAL UNLIMITED COMPANY, Dublin (IE)
Filed on Jun. 30, 2021, as Appl. No. 17/363,738.
Application 16/669,743 is a division of application No. 15/629,672, filed on Jun. 21, 2017, granted, now 10,494,660.
Application 15/629,672 is a division of application No. 14/357,561, granted, now 9,695,464, issued on Jul. 4, 2017, previously published as PCT/EP2012/072336, filed on Nov. 9, 2012.
Application 17/363,738 is a continuation of application No. 16/669,743, filed on Oct. 31, 2019, granted, now 11,085,066.
Claims priority of application No. 1119515 (GB), filed on Nov. 11, 2011; application No. 1201154 (GB), filed on Jan. 24, 2012; and application No. 1201245 (GB), filed on Jan. 25, 2012.
Prior Publication US 2021/0332410 A1, Oct. 28, 2021
Int. Cl. C12Q 1/26 (2006.01); C12Q 1/60 (2006.01); C12Q 1/61 (2006.01); G01N 33/92 (2006.01)
CPC C12Q 1/60 (2013.01) [C12Q 1/61 (2013.01); G01N 33/92 (2013.01)] 11 Claims
OG exemplary drawing
 
1. A method for correcting a high density lipoprotein (HDL) assay, said method comprising:
obtaining a total cholesterol (CH) value for a sample;
obtaining a measured high density lipoprotein (HDL) value for the sample;
calculating a non-HDL value by subtracting the measured HDL value from the CH value;
calculating a corrected HDL value using a function relating the non-HDL value and an increase in HDL, wherein said corrected HDL value is calculated by subtracting said increase in HDL from said measured HDL value.